SUO Annual Meeting: Street Team

Videos

Study results revealed the impact of a rurally focused telemedicine program on patient outcomes.

Adam J. Gadzinski, MD, MS, on the Limitations of a Study Assessing the Impact of Telemedicine on Patient-Reported Outcomes

Vikram Narayan, MD, expanded on his data regarding nadofaragene and NMIBC published at this year’s SUO Meeting.

Narayan on Complete Responses, Biomarkers, and Side Effects of Nadofaragene Treatment for NMIBC

Declan Murphy discusses the accuracy findings from the proPSMA study presented at the 2020 SUO Meeting.

Comparing Accuracy Findings from the proPSMA Study for PSMA PET/CT and Conventional Imaging

Declan Murphy discusses the motivation behind the proPSMA study and the emerging history of PSMA PET/CT to challenge conventional imaging at the 2020 SUO Meeting.

Declan Murphy on PSMA Molecules and the Motivation Behind the proPSMA Trial

Data presented at SUO indicated that MK-6482 demonstrated durable efficacy in patients with Von Hippel-Lindau disease-associated clear cell renal cell carcinoma, pancreatic lesions, and hemangioblastomas by targeting the underlying pathophysiology of the disease.

Ramaprasad Srinivasan, MD, PhD, on the Design of the Study of MK-6482 in VHL-Associated Disease

Declan Murphy talked about the future of PSMA theranostics to target metastatic castration-resistant prostate cancer.

Declan Murphy on Theranostics and Future of PSMA PET/CT for Prostate Cancer

Narayan discusses what he thinks the future of nadofaragene firadenovec and bladder cancer are at this year’s SUO Meeting.

Vikram Narayan, MD, on the Future of Nadofaragene Firadenovec and Bladder Cancer

The study assessed the impact of a rurally focused telemedicine program on patient outcomes in the urologic oncology outpatient clinic at the University of Washington Medical Center.

Adam J. Gadzinksi, MD, MS, on the Impact of Telemedicine on Patient-Reported Outcomes

The study sought to determine the impact of a rurally focused telemedicine program on patient outcomes.

Adam J. Gadzinski, MD, MS, on the Design of a Study Assessing Impact of Telemedicine on Patient-Reported Outcomes

The kidney cancer expert from the National Cancer Institute spoke about what ongoing research in the field of kidney cancer is most encouraging and where research should continue to be focused.

SUO Annual Meeting: Street Team | Conference